⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Announces Securities Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Pomerantz LLP Announces Commencement of Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
JSPR
Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
JSPR
Jasper Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
JSPR
JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
JSPR
Pomerantz LLP Announces Securities Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Pomerantz LLP Announces Commencement of Class Action Lawsuit Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR
Pomerantz LLP Announces Commencement of Class Action Litigation Against Jasper Therapeutics, Inc. – JSPR
accessnewswire.com
JSPR